racemetirosine has been researched along with DiGeorge Syndrome in 2 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
DiGeorge Syndrome: Congenital syndrome characterized by a wide spectrum of characteristics including the absence of the THYMUS and PARATHYROID GLANDS resulting in T-cell immunodeficiency, HYPOCALCEMIA, defects in the outflow tract of the heart, and craniofacial anomalies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verschure, DO | 1 |
| Boot, E | 1 |
| van Amelsvoort, TA | 1 |
| Booij, J | 1 |
| van Eck-Smit, BL | 1 |
| Somsen, GA | 1 |
| Verberne, HJ | 1 |
| Carandang, CG | 1 |
| Scholten, MC | 1 |
2 other studies available for racemetirosine and DiGeorge Syndrome
| Article | Year |
|---|---|
Cardiac sympathetic activity in 22q11.2 deletion syndrome.
Topics: 3-Iodobenzylguanidine; Adult; alpha-Methyltyrosine; DiGeorge Syndrome; Female; Heart; Humans; Image | 2016 |
Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report.
Topics: Adolescent; alpha-Methyltyrosine; Ambulatory Care; Chromosome Deletion; Chromosomes, Human, Pair 22; | 2007 |